Private-equity firm Veritas Capital will buy the healthcare business of Thomson Reuters for $1.25 billion in cash.
The sale, which was announced in late April, was expected to close in a few months. Thomson Reuters had re-launched a sales process for the unit earlier this year.
The healthcare business provides data, analytics and other services to companies, government agencies and healthcare professionals. Its brands include MarketScan, Advantage Suite, Micromedex, CareDiscovery and ActionOI, coupled with expert services and analysis.
CEO Mike Boswood will continue to be in charge of the business, said Veritas Capital’s chairman, Robert McKeon, in a statement.
From the June 01, 2012 Issue of MM+M - Medical Marketing and Media
